| Literature DB >> 35145814 |
Arunesh Gupta1, Vineet Kumar2, Amit R Peswani1, Aneesh Suresh1.
Abstract
Introduction Creating an arteriovenous fistula (AVF) to provide a patent and long-term vascular access (VA) for hemodialysis (HD) still remains a challenge. A methodical approach to choosing the appropriate HD access in accordance with patients' end-stage kidney disease (ESKD) life plan will help them achieve their goals safely. This study summarizes the impact of various factors on the AVF outcomes in an Indian population as well as the necessary considerations before choosing the site of AVF creation. Materials and methods This study involved a single-center, retrospective evaluation of all patients who had undergone arteriovenous (AV) access creation for maintenance HD from October 2018 to August 2019 at a center in India. Results In our study of 216 cases, the average age at presentation was 43.9 years and the difference in age between the successful and unsuccessful group was not significant. The successful outcomes in males were significantly higher than those in females (p=0.005). The mean venous diameter in the successful group was significantly larger than that in the unsuccessful group. The distal arterial and vein diameter was higher in both males and females of the laborer group compared to the clerical group; however, the outcomes were comparable. The overall complication rate was 22.22%. We had primary patency rates of 83% at the end of one year with a primary failure rate of 8.80%. Conclusion Vein diameter was the most important predictive factor for a successful outcome in our study. Factors like age and life expectancy, gender, comorbidities, occupation, and type of anastomosis may not be individually predictive of outcomes but need to be considered before choosing the appropriate site of access creation according to the life plan of the patient. This will reduce morbidity associated with an additional procedure and facilitate the initiation of HD as early as possible. Occupation can be considered as a surrogate for preoperative forearm exercises with the increased caliber of vessels found in people performing heavy/manual labor favoring a more distal AVF creation.Entities:
Keywords: arteriovenous fistula; chronic kidney disease; haemodialysis; predictive factors; renal transplantation; vascular access
Year: 2022 PMID: 35145814 PMCID: PMC8811729 DOI: 10.7759/cureus.20921
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Evaluation parameters in the perioperative period
GFR: glomerular filtration rate
| Preoperative evaluation | Intraoperative evaluation | Postoperative evaluation |
| Occupation | Diameter of the artery and vein | Any complications in the postoperative period like bleeding, hematoma, infection, thrombosis |
| Hand dominance | Presence of atherosclerosis | Patency of fistula at 1, 3, 6 months, 1 year, and then yearly thereafter |
| History of diabetes mellitus, cardiovascular disease, peripheral arterial disease, anticoagulant therapy | Visible arterial pulsations | |
| Recent puncture near the planned site of fistula creation | Immediate venous dilatation after anastomosis | |
| Timing of the previous hemodialysis | Presence of thrill after anastomosis | |
| Physical examination of arterial pulses and venous system | ||
| Allen’s test | ||
| GFR <30 ml/min | ||
| Preoperative documentation of vein and artery diameter by Doppler |
Postoperative protocol
| Postoperative protocol |
| Tab amoxicillin-clavulanic acid 625 mg twice a day for 5 days |
| Tab pantoprazole 40 mg once a day for 5 days |
| Tab paracetamol 500 mg SOS if pain persists for 5 days |
| Tab aspirin 75 mg once a day for 15 days |
| Left/right upper limb elevation |
| Handball exercises/elbow exercises after 24 hours (to be continued) |
| Avoid dialysis for the next 24 hours |
| Heparin-free dialysis for one week |
| Watch for bleeding; if bleeding occurs, report stat |
| Do not take blood pressure measurements from the fistula arm |
| Do not have any blood tests taken from the fistula arm |
| No needles, infusions, or drips go into the fistula arm |
| Do not wear any tight or restrictive clothing on the fistula arm |
| Avoid sleeping on the fistula arm |
| Do not use sharp objects near the fistula arm, e.g., razors |
| Avoid carrying heavy loads or shopping bags directly over the fistula |
| Do not remove the scabs from the needle sites as this may cause bleeding or an infection |
| Fistula can be used for dialysis after 6 weeks |
| Follow up after two days for wound check and after 10 days for suture removal |
Mean age of both outcome groups
SD: standard deviation
| Success | Age in years (mean ± SD) | Test | P-value |
| Yes (n=197) | 43.8 ± 14.9 | Unpaired t-test | 0.8253 |
| No (n=19) | 44.6 ± 16.2 |
Arteriovenous fistula outcomes in males and females
Chi-square test p=0.005
| Sex | Arteriovenous fistula outcome | ||
| Successful | Unsuccessful | Total | |
| Females (n) | 62 | 12 | 74 |
| Proportion | 83.78% | 16.22% | 100.00% |
| Males (n) | 135 | 7 | 142 |
| Proportion | 95.07% | 4.93% | 100.00% |
| Total (n) | 197 | 19 | 216 |
| Proportion | 91.20% | 8.80% | 100.00% |
Arteriovenous fistula outcome in diabetics
Chi-square test p=0.91
| Diabetes | Successful outcome | ||
| Yes | No | Total | |
| Yes (n) | 33 | 3 | 36 |
| Proportion | 91.67% | 8.33% | 100.00% |
| No (n) | 164 | 16 | 180 |
| Proportion | 91.11% | 8.89% | 100.00% |
| Total (n) | 197 | 19 | 216 |
| Proportion | 91.20% | 8.80% | 100.00% |
Mean artery and vein diameter of both outcome groups
SD: standard deviation
| Successful outcome | Vein diameter (mean ± SD) | Test | P-value |
| Yes (n=197) | 2.4 ± 0.7 | Unpaired t-test | 0.0004 |
| No (n=19) | 1.9 ± 0.5 | ||
| Artery diameter (mean ± SD) | |||
| Yes (n=197) | 2.5 ± 0.5 | Unpaired t-test | 0.2225 |
| No (n=19) | 2.3 ± 0.4 |
Figure 1Comparison of the mean artery and vein diameter in end-to-side vs. end-to-end anastomosis
Mean artery and vein diameter of distal arteriovenous fistula in males
SD: standard deviation
| Group | Vein diameter (mean ± SD) | Test | P-value |
| Clerical (n=197) | 2.3 ± 0.6 | Unpaired t-test | 0.35 |
| Laborer (n=19) | 2.5 ± 0.6 | ||
| Artery diameter (mean ± SD) | |||
| Clerical (n=197) | 2.2 ± 0.3 | Unpaired t-test | 0.03 |
| Laborer (n=19) | 2.4 ± 0.3 |
Mean artery and vein diameter of distal arteriovenous fistula in females
SD: standard deviation
| Group | Vein diameter (mean ± SD) | Test | P-value |
| Clerical (n=21) | 1.9 ± 0.5 | Unpaired t-test | 0.34 |
| Laborer (n=78) | 2.1 ± 0.5 | ||
| Artery diameter (mean ± SD) | |||
| Clerical (n=21) | 2.2 ± 0.3 | Unpaired t-test | 0.05 |
| Laborer (n=78) | 2.4 ± 0.3 |
Summary of the complications in our study
| Complications | Frequency | Percentage |
| Aneurysm formation | 1 | 0.46% |
| Bleeding from clip slippage | 1 | 0.46% |
| Edema | 22 | 10.19% |
| Hematoma formation | 3 | 1.39% |
| Perioperative cellulitic changes - resolved | 1 | 0.46% |
| Postoperative bleeding due to slippage of clip | 1 | 0.46% |
| Thrombosis | 19 | 8.80% |
| No complication | 168 | 77.78% |
| Total | 216 | 100.00% |
Predictive factors of successful outcomes after arteriovenous fistula creation
| Variable | Coefficient | Standard error | P-value | Odds ratio | 95% confidence interval |
| Age | -0.0147 | 0.0205 | 0.4733 | 0.9854 | (0.9465-1.0258) |
| Gender | -0.9751 | 0.5352 | 0.0685 | 0.3772 | (0.1321-1.0767) |
| Diabetes mellitus | 0.3347 | 0.7574 | 0.6586 | 1.3975 | (0.3167-6.1661) |
| Type of anastomosis | -0.3768 | 0.4924 | 0.4442 | 0.6861 | (0.2613-1.8010) |
| Artery | -0.3779 | 0.5919 | 0.5232 | 0.6853 | (0.2148-2.1863) |
| Vein | 1.8552 | 0.6415 | 0.0038 | 6.3932 | (1.8183-22.4780) |
| Constant | 1.9065 | 2.0145 | 0.3440 |